The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The contribution of mass drug administration to global health: past, present and future
Open accessAbstract
Mass drug administration (MDA) is a means of delivering safe and inexpensive essential medicines based on the principles of preventive chemotherapy, where populations or sub-populations are offered treatment without individual diagnosis. High-coverage MDA in endemic areas aims to prevent and alleviate symptoms and morbidity on the one hand and can reduce transmission on the other, together improving global health. MDA is the recommended strategy of the World Health Organisation to control or eliminate several neglected tropical diseases (NTDs). More than 700 million people now receive these essential NTD medicines annually. The combined cost of integrated NTD MDA has been calculated to be in the order of $0.50 per person per year. Activities have recently been expanded due, in part, to the proposed attempt to eliminate certain NTDs in the coming two decades. More than 1.9 billion people need to receive MDA annually across several years if these targets are to be met. Such extensive coverage will require additional avenues of financial support, expanded monitoring and evaluation focusing on impact and drug efficacy, as well as new diagnostic tools and social science strategies to encourage adherence. MDA is a means to help reduce the burden of disease, and hence poverty, among the poorest sector of populations. It has already made significant improvements to global health and productivity and has the potential for further successes, particularly where incorporated into sanitation and education programmes. However logistical, financial and biological challenges remain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Ariey, F., Witkowski, B., Amaratunga, C., Beghain, J., Langlois, A.-C., Khim, N., Kim, S., Duru, V., Bouchier, C., Ma, L., et al. (2014) · Nature · doi:10.1038/nature12876 · Cited by 2,090
Disease and Development: Evidence from Hookworm Eradication in the American South
Bleakley, H. (2007) · The Quarterly Journal of Economics · doi:10.1162/qjec.121.1.73 · Cited by 992
Rescuing the bottom billion through control of neglected tropical diseases
Hotez, P. J., Fenwick, A., Savioli, L., & Molyneux, D. H. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60233-6 · Cited by 944
Self-citationKing, C. H., Dickman, K., & Tisch, D. J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66457-4 · Cited by 899
Biological and biomedical implications of the co-evolution of pathogens and their hosts
Woolhouse, M. E. J., Webster, J. P., Domingo, E., Charlesworth, B., & Levin, B. R. (2002) · Nature Genetics · doi:10.1038/ng1202-569 · Cited by 869
Self-citationHotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E., Ehrlich Sachs, S., & Sachs, J. D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030102 · Cited by 817
Self-citationKeiser, J., & Utzinger, J. (2008) · JAMA · doi:10.1001/jama.299.16.1937 · Cited by 798
Population Biology of Multihost Pathogens
Woolhouse, M. E. J., Taylor, L. H., & Haydon, D. T. (2001) · Science · doi:10.1126/science.1059026 · Cited by 768
Lymphatic filariasis and onchocerciasis
Taylor, M. J., Hoerauf, A., & Bockarie, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60586-7 · Cited by 686 · cited 1×
“At present, the duration of the required antibiotic course is four to six weeks and hence cannot be used at scale for MDA, although could be used in restricted settings under medical supervision, for example where there has been evidence of reduced efficacy of the standard anti-filarial drugs [13].”
BackgroundMolyneux, D. H., Hotez, P. J., & Fenwick, A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020336 · Cited by 557
Self-citation
Cited by
Neglected tropical diseases: progress towards addressing the chronic pandemic
Molyneux, D. H., Savioli, L., & Engels, D. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30171-4 · Cited by 376
Self-citationThe public health control of scabies: priorities for research and action.
Engelman, D., Cantey, P. T., Marks, M., Solomon, A. W., Chang, A. Y., Chosidow, O., Enbiale, W., Engels, D., Hay, R. J., Hendrickx, D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31136-5 · Cited by 223
Self-citationHeimburg, T., Chakrabarti, A., Lancelot, J., Marek, M., Melesina, J., Hauser, A.-T., Shaik, T. B., Duclaud, S., Robaa, D., Erdmann, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01478 · Cited by 124
Benjamin-Chung, J., Crider, Y. S., Mertens, A., Ercumen, A., Pickering, A. J., Lin, A., Steinbaum, L., Swarthout, J., Rahman, M., Parvez, S. M., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30523-4 · Cited by 39
Mduluza, T., Jones, C., Osakunor, D. N. M., Lim, R., Kuebel, J. K., Phiri, I., Manangazira, P., Tagwireyi, P., & Mutapi, F. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008388 · Cited by 29
Metadata
- Authors
- Webster, J. P., Molyneux, D. H., Hotez, P. J., & Fenwick, A.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2014-06-19
- Volume
- 369
- Issue
- 1645
- Pages
- 20130434
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2099269010
- Cited by
- 307
- References
- 71
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The contribution of mass drug administration to global health: past, present and future. https://app.cochat.ai/papers/10.1098/rstb.2013.0434
- The paper
- Webster, J. P., Molyneux, D. H., Hotez, P. J., & Fenwick, A. (2014). The contribution of mass drug administration to global health: past, present and future. Philosophical Transactions of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rstb.2013.0434
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.